Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Search Results for: clinical trials – Page 5

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?

The methodologies for testing MRD are evolving and finding less than 1 in 10,000 cells by flow cytometry is today’s standard definition for undetectable minimal or measurable residual disease (uMRD). There is good reason to believe that the deeper levels achievable with next generation gene sequencing (NGS), capable of finding a single cancer cell in a million cells, may be even more valuable, especially with cellular therapies such as CAR-T and transplants.

ASH 2019: Dr. Parikh Discusses Clinical Trial of Early Intervention in High-Risk CLL Patients

ASH 2019, Dr. John Pagel interviews Dr. Sameer Parikh regarding a clinical trial out of all locations of the Mayo Clinic investigating the potential benefit of early intervention of high-risk CLL and SLL patients, as determined by the Prognostic CLL International Prognostic Index (IPI), with treatment regimens of either acalabrutinib or acalabrutinib + obinituzumab for a fixed duration of 2 years.

Why I Participate in a Clinical Trial

By Julia Walsh – Patient When I was diagnosed in 2013, my treatment options were limited.  I saw a community hematology-oncology doctor who told me that I would likely receive FCR,

The Role of the Clinical Trial Nurse

A video interview between Terry Evans, CLL patient and Sheila Hoff, RN, Clinical Trial Nurse at the University of California, San Diego, Moores Cancer Center. (See video at the bottom of

Didn't find what you where looking for?

Try our advanced search page!